Wendy L. See
- Molecular Biology
- Hematology top 5%
- Genetics top 5%
- Cancer Research
- Oncology
- Co-authors
- Russell O. PieperJoydeep MukherjeeShigeo OhbaKyle J. MacBethQiang XuMark G. FrattiniI‐Li TanEytan M. Stein
- Topics
- Acute Myeloid Leukemia Research (14 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers)Multiple Myeloma Research and Treatments (4 papers)
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Wendy L. See
20 papers receiving 547 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 326
- Hematology 248
- Genetics 179
- Cancer Research 121
- Oncology 102
Countries citing papers authored by Wendy L. See
This map shows the geographic impact of Wendy L. See's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy L. See with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy L. See more than expected).
Fields of papers citing papers by Wendy L. See
This network shows the impact of papers produced by Wendy L. See. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy L. See. The network helps show where Wendy L. See may publish in the future.
Co-authorship network of co-authors of Wendy L. See
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy L. See. A scholar is included among the top collaborators of Wendy L. See based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy L. See. Wendy L. See is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 26 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 79 | |
| 13 | 1 | |
| 14 | 165 | |
| 15 | 24 | |
| 16 | 62 | |
| 17 | 79 | |
| 18 | 21 | |
| 19 | 26 | |
| 20 | 52 |
About Wendy L. See
Wendy L. See is a scholar working on Hematology, Genetics and Oncology, having authored 20 papers that have together received 557 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Hematology (248 citations), Genetics (179 citations) and Cancer Research (121 citations). Wendy L. See has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Russell O. Pieper, Joydeep Mukherjee, Shigeo Ohba, Kyle J. MacBeth, Qiang Xu, Mark G. Frattini, I‐Li Tan, Eytan M. Stein, Robert H. Collins and Daniel A. Pollyea. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.